A new day for myeloid genomic profiling: how NGS advancements are providing deeper insight with faster time to results
The use of genomic profiling for myeloid samples has accelerated in recent years due in part to increasing annotation of disease-associated biomarkers. As this list of relevant biomarkers continues to expand, traditional single-gene testing approaches are becoming infeasible.
In this webinar, we showcase the Ion Torrent Oncomine Myeloid Assay GX, the first myeloid genomic profiling solution that can deliver next-generation sequencing results in a single day. Learn how this solution addresses key challenges in myeloid molecular testing and see recent data from Dr. Kojo Elenitoba-Johnson of the Perelman School of Medicine at the University of Pennsylvania.
Dr. Kojo Elenitoba-Johnson
Perelman School of Medicine at the University of Pennsylvania
Dr. Andy Felton
Thermo Fisher Scientific
Please fill out this brief form to access the webinar. If you would like a personal demonstration from a Thermo Fisher representative, please select that option.